-
1
المؤلفون: Randeep Sangha, Laurie H. Sehn, Rahima Jamal, Jennifer Spratlin, John Kuruvilla, Michael J. Weickert, Luc G. Berthiaume, John R. Mackey
المصدر: Blood. 140:12057-12058
مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::544f0500c7edc962441994f8ac3d8878Test
https://doi.org/10.1182/blood-2022-168140Test -
2
المؤلفون: Luc G. Berthiaume, Randeep Sangha, Laurie H. Sehn, John Kuruvilla, John R. Mackey, Michael J. Weickert
المصدر: Blood. 138:1364-1364
مصطلحات موضوعية: business.industry, Computer science, Immunology, Phase (waves), Pattern recognition, Cell Biology, Hematology, Artificial intelligence, First in human, Open label, business, Biochemistry
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::26ca37cfc764618c3d732f42bc97a5b4Test
https://doi.org/10.1182/blood-2021-153613Test -
3
المؤلفون: Luc G. Berthiaume, Randeep Sangha, Caren Brown, Michael J. Weickert, John Dillberger, Francis Phaneuf, John R. Mackey
المصدر: Blood. 136:40-41
مصطلحات موضوعية: Body surface area, business.industry, Immunology, Cmax, Cell Biology, Hematology, Pharmacology, medicine.disease, Biochemistry, Lymphoma, Bioavailability, Dasatinib, chemistry.chemical_compound, chemistry, Apoptosis, Ibrutinib, Toxicity, medicine, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8321a5588541bec4e0c931bb390b58e5Test
https://doi.org/10.1182/blood-2020-141910Test -
4
المؤلفون: John Kuruvilla, Laurie H. Sehn, Luc G. Berthiaume, Randeep Sangha, John R. Mackey, Michael J. Weickert
المصدر: Journal of Clinical Oncology. 38:TPS3656-TPS3656
مصطلحات موضوعية: Cancer Research, business.industry, First in human, Cell biology, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Medicine, Cancer biology, Open label, Signal transduction, business, 030215 immunology, Myristoylation
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3315f44e4189d539c5afa5447c8d822cTest
https://doi.org/10.1200/jco.2020.38.15_suppl.tps3656Test -
5
المؤلفون: Randeep Sangha, Loretta J. Nastoupil, John Kuruvilla, Leonard M. Klein, Patrick Hagner, Armando Santoro, Ian W. Flinn, Vaishalee P. Kenkre, David Andorsky, Vincent Ribrag, Paolo Corradini, Kristen Hege, Shailaja Uttamsingh, Fontanet Bijou, Anita Gandhi, Daniel Reif Greenwald, Tianlei Chen, Thomas E. Witzig, Michael Pourdehnad, Julio C. Chavez
المصدر: Blood. 132:1602-1602
مصطلحات موضوعية: 0301 basic medicine, education.field_of_study, medicine.medical_specialty, business.industry, Immunology, Population, Early Relapse, Patient characteristics, Cell Biology, Hematology, Biochemistry, Fixed dose, 03 medical and health sciences, Safety profile, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Family medicine, medicine, Dose reduction, Rituximab, In patient, education, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bbf11587d9aa17bf0d9ac23aae68a0efTest
https://doi.org/10.1182/blood-2018-99-114409Test -
6
المؤلفون: Elizabeth H Phillips, Robert Marcus, Randeep Sangha, Günter Fingerle-Rowson, Marek Trněný, Stephen Opat, Wolfram Klapper, Michael Herold, Carolyn Owen, Tom Moore, Wolfgang Hiddemann, Andrew Davies, Michael Wenger, Kaspar Rufibach, William Townsend, Kiyoshi Ando, John F. Seymour, Rudolf Schlag
المصدر: Blood. 128:6-6
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Immunology, Follicular lymphoma, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Obinutuzumab, Internal medicine, Clinical endpoint, Medicine, In patient, Progression-free survival, Cell-mediated cytotoxicity, Until Disease Progression, business.industry, Cell Biology, Hematology, medicine.disease, 030104 developmental biology, Cell killing, chemistry, 030220 oncology & carcinogenesis, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::252109011adfdf5037f165984018db2cTest
https://doi.org/10.1182/blood.v128.22.6.6Test -
7
المؤلفون: Armando Santoro, Ian W. Flinn, Jason C. Chandler, Paolo Corradini, Torsten Trowe, Julio C. Chavez, Jason B. Kaplan, Xiaoling Wu, Vaishalee P. Kenkre, Patrick Hagner, Randeep Sangha, Kristen Hege, Vincent Ribrag, Anita Gandhi, Umberto Vitolo, Ranjana H. Advani, Iris Isufi, John Kuruvilla, Michael Pourdehnad, Philippe A. Cassier
المصدر: Blood. 128:1849-1849
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Immunology, Population, 01 natural sciences, Biochemistry, Fixed dose, 03 medical and health sciences, Open label study, medicine, Dose escalation, education, Complete response, education.field_of_study, 010405 organic chemistry, business.industry, Cell Biology, Hematology, Peripheral blood, 0104 chemical sciences, 030104 developmental biology, Family medicine, Rituximab, business, Early phase, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::91df41c9314e574029609df96e491215Test
https://doi.org/10.1182/blood.v128.22.1849.1849Test -
8
المؤلفون: Michael B. Sawyer, Michael P. Chu, Randeep Sangha, Andrew Belch, Neil Chua, Sunita Ghosh, Jessica R. Lieffers, Amelie Fontaine, A. Robert Turner
المصدر: Blood. 122:5078-5078
مصطلحات موضوعية: medicine.medical_specialty, Performance status, business.industry, Immunology, Hazard ratio, Follicular lymphoma, Cell Biology, Hematology, medicine.disease, Biochemistry, Gastroenterology, Chemotherapy regimen, Surgery, International Prognostic Index, Sarcopenia, Internal medicine, medicine, Rituximab, Progression-free survival, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::936533a4a479417ea7978402e353440cTest
https://doi.org/10.1182/blood.v122.21.5078.5078Test -
9
المؤلفون: Randeep Sangha, Andrew Davies, Nam H. Dang, Michinori Ogura, David A. MacDonald, Angela Volkert, Revathi Ananthakrishnan, Kenneth Luu, Joseph P. Boni, Erik Vandendries, Yeow-Tee YT Goh
المصدر: Blood. 122:1821-1821
مصطلحات موضوعية: Inotuzumab ozogamicin, medicine.medical_specialty, education.field_of_study, business.industry, Immunology, Population, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Gemcitabine, Surgery, Regimen, Tolerability, hemic and lymphatic diseases, Internal medicine, medicine, Rituximab, business, education, Febrile neutropenia, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::74d1d5b263f87368f7d6d7ffe2168e98Test
https://doi.org/10.1182/blood.v122.21.1821.1821Test -
10
المؤلفون: A. Robert Turner, Randeep Sangha, Michael B. Sawyer, Amelie Fontaine, Andrew Belch, Neil Chua, Michael P. Chu, Jessica R. Lieffers, Sunita Ghosh
المصدر: Blood. 122:3023-3023
مصطلحات موضوعية: Oncology, education.field_of_study, medicine.medical_specialty, Performance status, business.industry, Immunology, Population, Hazard ratio, Cell Biology, Hematology, medicine.disease, Biochemistry, Surgery, International Prognostic Index, Chemoimmunotherapy, Sarcopenia, Internal medicine, Medicine, Progression-free survival, business, education, Diffuse large B-cell lymphoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0b6f579ba5ae16f2a6ed1a62201d615aTest
https://doi.org/10.1182/blood.v122.21.3023.3023Test